Dementia causes a substantial global economic burden, but effective treatment is lacking.
Recently, studies have revealed that gamma-band waves of electrical brain activity …

Introduction The abnormal amyloid β (Aβ) accumulation and Aβ-related neural network
dysfunction are considered central to the pathogenesis of Alzheimer's disease (AD) at the …

Despite decades of research, Alzheimer's Disease (AD) remains a lethal neurodegenerative
disorder for which there are no effective treatments. This review examines the latest …

Objective In Alzheimer disease (AD) animal models, synaptic dysfunction has recently been
linked to a disorder of high‐frequency neuronal activity. In patients, a clear relation between …

Despite the numerous pharmacological interventions targeting dementia, no disease-
modifying therapy is available, and the prognosis remains unfavorable. A promising …

Abstract Gamma oscillations (30–80 Hz) are well-known for their role in cortical signal
transmission and cognitive brain functions. Aberrant gamma activity has been observed in …

Cognitive impairment, functional decline and behavioral symptoms that characterize
Alzheimer's disease (AD) are associated with perturbations of the neuronal network. The …

Alzheimer's disease (AD) is characterized by reduced fast brain oscillations in the gamma
band (γ,> 30 Hz). Several animal studies show that inducing gamma oscillations through …

Background As an increasing population of Alzheimer's disease (AD) patients year by year,
which is a serious threat to human health, an effective approach to prevent and treat AD is …

Pathological proteins contributing to Alzheimer's disease (AD) are known to disrupt normal
neuronal functions in the brain, leading to unbalanced neuronal excitatory-inhibitory tone …